Effects of Esculentoside A on Proliferation of Human Keratinocytes in Vitro

Junbao Du
2006-01-01
Abstract:Objective To investigate the anti-proliferative effects of Esculentoside A (EsA) on keratinocytes (KC) in vitro that eventually would lead to new therapeutic options for psoriasis.Methods Whole,heparinized peripheral blood was donated by 30 patients with PV and 20 healthy controls.PBMCs were isolated by density centrifugation and stimulated with a mitogen (PHA) for 48 hours in the presence or absence of EsA.Skin specimens obtained from 10 healthy children undergoing circumcision were dissociated into single keratinocytes suspensions by trypsin.These different types of cell were co-cultured in serum-free Defined Keratinocyte-SFM medium.Proliferation of KC was assessed by MTT colorimetry.Results EsA showed no significant inhibition on the proliferation of PBMC induced by PHA.EsA could directly anti-proliferate KC cultured in keratinocyte serum-free medium (KSFM) in vitro.KC proliferation was significantly decreased during the concentration of EsA over 1.0 μg/ml,compared to the non-stimulated controls(P0.05).And the addition of increasing doses (5.0~10.0 μg/ml) of EsA resulted in a dose-dependent inhibition in PBMC’s proliferation effect on KC in vitro(P0.01).Conclusion EsA didn’t inhibit lymphocytes proliferation in vitro,which could probably bring to light that EsA mainly targeted mono-macropgage in the systemic treatment of PV.PBMCs isolated from psoriasis patients could markedly stimulate human epidermis KC.EsA could directly anti-proliferate KC cultured in KSFM and block or inhibit PBMC’s proliferation effect on KC as well,in vitro.
What problem does this paper attempt to address?